MAPT and Alzheimer disease: It was shown that ERK 1 and 2 are expressed in the pooled cerebrospinal fluid (CSF) of patients with AD, and elevated levels of ERK 1/2 in CSF are accompanied by increased levels of tau protein and the Aβ42 peptide [45].